Magnesium for Sleep: The Complete Science Guide

Magnesium is involved in over 300 enzymatic reactions in the body and plays particularly important roles in neurological function. Its relevance to sleep stems from four core mechanisms: GABA receptor modulation (the primary inhibitory neurotransmitter system), NMDA receptor antagonism (blocking excitatory glutamate activity), cortisol regulation (reducing HPA axis output), and melatonin synthesis support (acting as a co-factor in the tryptophan-serotonin-melatonin pathway). These are not peripheral effects - they are central to the neurophysiology of sleep onset and maintenance. Magnesium deficiency produces the opposite of each: increased neural excitability, elevated cortisol, impaired melatonin production, and disrupted sleep architecture.

Population data consistently shows that a substantial proportion of adults in Western countries have dietary magnesium intake below the Recommended Daily Allowance (RDA: 300-420mg/day depending on sex and age). The 2005-2006 US National Health and Nutrition Examination Survey found that 60% of adults consumed less magnesium than the EAR (estimated average requirement). UK NDNS data shows similar patterns. Subclinical deficiency is exacerbated by: high alcohol intake (which increases renal magnesium excretion), chronic stress (increases urinary magnesium loss), diets dominated by processed food (magnesium is lost in refining), Type 2 diabetes and insulin resistance (increased urinary loss), and some medications (proton pump inhibitors, diuretics, antibiotics).

Clinical evidence for magnesium's sleep benefits is most robust in populations with depleted status. The Abbasi et al. (2012) trial in older adults with insomnia found 8 weeks of 500mg magnesium significantly improved sleep onset latency, sleep efficiency, total sleep time, and morning serum cortisol compared to placebo. A 2021 meta-analysis in BMC Complementary Medicine and Therapies reviewed 9 trials and found that magnesium supplementation significantly improved subjective sleep quality and reduced insomnia severity, with the strongest effects in older adults. Importantly, the mechanism is not the same as a sedative - magnesium does not force sleep or produce next-day sedation. It restores the physiological conditions for sleep in individuals whose magnesium status is suboptimal.

Magnesium glycinate is the most evidence-aligned form for sleep. It combines well-established sleep benefits of magnesium with glycine's independent sleep mechanisms (peripheral vasodilation and core body temperature reduction). Bioavailability is approximately 40-60%, far superior to magnesium oxide (4%). Magnesium L-threonate is specifically engineered for blood-brain barrier penetration and may have superior effects on central nervous system magnesium, but the evidence base is smaller and the cost is higher. Magnesium citrate has decent bioavailability but lacks glycine's temperature-lowering effect. Magnesium oxide is present in many supermarket products and is essentially ineffective at clinically meaningful doses due to poor absorption.

Taking magnesium 1-2 hours before bed aligns the peak plasma magnesium with the sleep initiation window. Glycine's core body temperature effects peak approximately 90 minutes after ingestion, reinforcing the pre-bed timing for glycinate forms specifically. Magnesium can be taken with or without food. Some individuals find it mildly activating at very high doses, but this is uncommon with well-formulated products at standard doses. Splitting the dose (e.g. morning and evening) may improve tolerability but is not required for sleep benefit - the evening dose is pharmacologically primary for sleep purposes.